| Identification | Back Directory | [Name]
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-NLE-NH2 | [CAS]
57462-42-7 | [Synonyms]
[NLE11]-SUBSTANCE P
Substance P, [Nle11]
(Nle-NH211)-Substance P
[NLE11]-SUBSTANCE P ≥97%
NLE11]-SUBSTANCE P[NLE11
substance P, NleNH2(11)-
[Norleucinamide11]substance P
11-L-Norleucinamidesubstance P
[Nle11]-Substance P
Substance P,11-L-norleucinamide-
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-NLE-NH2
H-ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-NLE-NH2
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-NLE-NH2: RPKPQQFFGL-NLE-NH2 | [Molecular Formula]
C64H100N18O13 | [MDL Number]
MFCD00076785 | [MOL File]
57462-42-7.mol | [Molecular Weight]
1329.59 |
| Chemical Properties | Back Directory | [density ]
1.40±0.1 g/cm3(Predicted) | [storage temp. ]
−20°C
| [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
13.31±0.20(Predicted) | [Sequence]
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-{NLE}-NH2 |
| Hazard Information | Back Directory | [Uses]
[Nle11]-Substance P is a substance P analog that avoids methionine oxidation problems. | [References]
[1] Chipkin RE, et al. In vitro activities of some synthetic substance P analogs. Arch Int Pharmacodyn Ther. 1979 Aug;240(2):193-202. PMID:508003 |
|
|